January 19, 2026
RA Jainee
Nippon India Pharma Fund
| Fund at a Glance | |
| NAV Growth (Rs.) | 560.17 |
| NAV Bonus (Rs.) | 560.17 |
| NAV IDCW (Rs.) | 165.40 |
| Min. Investment (Rs.) | 5,000 |
| Min. SIP Investment (Rs.) | 100 |
| Min. No of Cheques | 60 |
| Benchmark | BSE Healthcare TRI |
| AUM Rs. | 8,265 Cr |
| (As on 31-Dec-2025) | |
| Expense | 0.92% |
| 1 Year Return (%) | 1.60 |
| 3 Year Return (%) | 22.20 |
| 5 Year Return (%) | 15.21 |
| 10 Year Return (%) | 14.66 |
| Return Since Launch | 17.30% |
⚖️ Sahifund Review – Nippon India Pharma Fund ✔
PLUS: Stability, track record, cost efficiency
X
MINUS: Large AUM, large-cap bias, momentum lag
X
Sahifund View (Decisive Line):
X
👉 Apply Online | Ask Us MF Queries |
| NFO Guidance |
What lies ahead? Below we decode returns consistency, portfolio concentration, peer positioning and risk profile in detail.
Suitable For Which Investors?
Nobody should invest in Pharma funds in our opinion, because:
• They have a narrow focus on only pharmaceutical and healthcare companies
• Instead, diversified equity funds which invest across sectors are better
If you still choose to invest:
1. Invest only through SIP
2. Have a 7+ year investment horizon
3. Be prepared to withstand interim sharp declines in investment value
Fund’s Investment Strategy:
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Fund Manager:
1) Sailesh Raj Bhan
Education: Mr. Bhan is an MBA (Finance) and CFA.
Experience: Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst – Equity Research.
Investment Details
| Min. Investment Assets (Rs) | 5,000 |
| Min. Addl Investment Assets (Rs) | 1,000 |
| Min. SIP Investment Assets (Rs) | 100 |
| Min. Withdrawal Assets (Rs) | 100 |
| Min. No of Cheques | 60 |
| Min. Balance Assets (Rs) | 1 |
| Lock-in Period | NA |
| Exit Load | 1% for redemption within 30 days |
Basic Details of Nippon India Pharma Fund
| Fund House | Nippon India Mutual Fund |
| Launch Date | 01-Jan-13 |
| Return Since Launch | 17.30% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets (Rs) | 8,265 Cr |
| (As on 31-Dec-2025) | |
| Expense | 0.92% |
| (As on 31-Dec-2025) | |
| Risk Grade | Average |
| Return Grade | Average |
| Turnover | 17.00% |
Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| Nippon India Pharma Dir | -1.69 | -1.11 | -1.52 | -2.14 | -4.15 | 1.60 | 22.20 | 15.21 | 19.55 | 14.66 |
| BSE Healthcare TRI | -2.16 | -1.16 | -2.00 | -4.06 | -5.17 | 1.24 | 23.75 | 14.92 | 17.83 | 11.28 |
| Equity: Sectoral-Pharma | -1.62 | -1.02 | -1.33 | -2.96 | -3.76 | 1.84 | 22.53 | 15.35 | 20.98 | 13.56 |
| Rank within category | 14 | 20 | 13 | 6 | 13 | 10 | 7 | 6 | 6 | 1 |
| Number of funds in category | 24 | 24 | 24 | 23 | 23 | 21 | 12 | 10 | 7 | 4 |
Peer Comparison of Nippon India Pharma Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs) (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| Nippon India Pharma Dir | 3 star | 1.60 | 22.20 | 15.21 | 0.92 | 8,265 | 17.30 | 1.00 (30) | 13Y | 17.00 |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 5 star | 2.65 | 27.41 | 17.51 | 1.02 | 6,456 | 20.98 | 1.00 (15) | 7Y 6M | 60.00 |
| SBI Healthcare Opportunities Dir | 4 star | 1.02 | 24.44 | 16.72 | 0.91 | 3,989 | 17.23 | 0.50 (15) | 13Y | 11.00 |
| DSP Healthcare Dir | 4 star | -3.68 | 22.04 | 16.06 | 0.61 | 3,114 | 22.60 | 0.50 (30) | 7Y 1M | 8.00 |
| UTI Healthcare Dir | 4 star | 0.60 | 24.42 | 15.18 | 1.28 | 1,102 | 15.55 | 1.00 (30) | 13Y | 31.00 |
Portfolio Analysis of Nippon India Pharma Fund
| No. of Stocks | 36 |
| Top 10 Stocks | 58.17% |
| Top 5 Stocks | 39.37% |
| Top 3 Sectors | 97.37% |
| Portfolio P/B Ratio | 5.56 |
| Portfolio P/E Ratio | 35.88 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 64,194 | 78,928 |
| Giant (%) | — | — |
| Large (%) | 39.71 | 43.92 |
| Mid (%) | 27.27 | 30.52 |
| Small (%) | 33.02 | 28.49 |
| Tiny (%) | — | — |
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Quicklinks
- Chanakyanipothi.com
- Staffavailable.com
- BigGaddi.com
- Latest IPO GMP
- Best Stocks to buy today
- Grey Market Premium
- Upcoming IPOs
- Subscription Status